Clinical trial
Early Detection Of Alzheimer's Disease With GlucoCEST MRI: A Feasibility Study.
NCT05614310 is registered in ClinicalTrials.gov with University of Aberdeen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Detection Of Alzheimer's Disease With GlucoCEST MRI: A Feasibility Study.
- Lead sponsor
- University of Aberdeen
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 15, 2022
- Completion date
- December 31, 2025
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.